Search Results - Rogier Versteeg

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Cell state plasticity in neuroblastoma by Adam D. Durbin, Rogier Versteeg

    Published in EJC Paediatric Oncology (2024-12-01)
    Get full text
    Article


  2. 2

    Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state. by Gisela Lundberg, Yuesheng Jin, Daniel Sehic, Ingrid Øra, Rogier Versteeg, David Gisselsson

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  3. 3

    Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells. by Serena Vella, Elisa Tavanti, Claudia Maria Hattinger, Marilù Fanelli, Rogier Versteeg, Jan Koster, Piero Picci, Massimo Serra

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  4. 4

    DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells. by M Emmy M Dolman, Ida van der Ploeg, Jan Koster, Laurel Tabe Bate-Eya, Rogier Versteeg, Huib N Caron, Jan J Molenaar

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  5. 5

    DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma by Thale Kristin Olsen, Cecilia Dyberg, Bethel Tesfai Embaie, Adele Alchahin, Jelena Milosevic, Jane Ding, Jörg Otte, Conny Tümmler, Ida Hed Myrberg, Ellen M. Westerhout, Jan Koster, Rogier Versteeg, Han-Fei Ding, Per Kogner, John Inge Johnsen, David B. Sykes, Ninib Baryawno

    Published in JCI Insight (2022-10-01)
    Get full text
    Article


  6. 6

    MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma by Thomas F. Eleveld, Thomas F. Eleveld, Lindy Vernooij, Linda Schild, Bianca Koopmans, Lindy K. Alles, Marli E. Ebus, Rana Dandis, Harm van Tinteren, Huib N. Caron, Jan Koster, Max M. van Noesel, Godelieve A. M. Tytgat, Selma Eising, Rogier Versteeg, M. Emmy M. Dolman, M. Emmy M. Dolman, M. Emmy M. Dolman, Jan J. Molenaar, Jan J. Molenaar

    Published in Frontiers in Oncology (2023-02-01)
    Get full text
    Article


  7. 7

    SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry by Bieke Decaesteker, Amber Louwagie, Siebe Loontiens, Fanny De Vloed, Sarah-Lee Bekaert, Juliette Roels, Suzanne Vanhauwaert, Sara De Brouwer, Ellen Sanders, Alla Berezovskaya, Geertrui Denecker, Eva D’haene, Stéphane Van Haver, Wouter Van Loocke, Jo Van Dorpe, David Creytens, Nadine Van Roy, Tim Pieters, Christophe Van Neste, Matthias Fischer, Pieter Van Vlierberghe, Stephen S. Roberts, Johannes Schulte, Sara Ek, Rogier Versteeg, Jan Koster, Johan van Nes, Mark Zimmerman, Katleen De Preter, Frank Speleman

    Published in Nature Communications (2023-03-01)
    Get full text
    Article


  8. 8

    A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities by Ravi S. Narayan, Piet Molenaar, Jian Teng, Fleur M. G. Cornelissen, Irene Roelofs, Renee Menezes, Rogier Dik, Tonny Lagerweij, Yoran Broersma, Naomi Petersen, Jhon Alexander Marin Soto, Eelke Brands, Philip van Kuiken, Maria C. Lecca, Kristiaan J. Lenos, Sjors G. J. G. In ‘t Veld, Wessel van Wieringen, Frederick F. Lang, Erik Sulman, Roel Verhaak, Brigitta G. Baumert, Lucas J. A. Stalpers, Louis Vermeulen, Colin Watts, David Bailey, Ben J. Slotman, Rogier Versteeg, David Noske, Peter Sminia, Bakhos A. Tannous, Tom Wurdinger, Jan Koster, Bart A. Westerman

    Published in Nature Communications (2020-06-01)
    Get full text
    Article


Search Tools: